{
    "nctId": "NCT00499083",
    "briefTitle": "Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)",
    "officialTitle": "Neoadjuvant Intratumoral Injection of Dendritic Cells in Breast Cancer Translation of Biotechnology Into the Clinic",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 17,
    "primaryOutcomeMeasure": "Number of Patients With Pathological Complete Response",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically confirmed invasive breast cancer meeting the following criteria:\n\n  * Primary tumor \u2265 3 cm by mammography, ultrasound, or palpation AND/OR palpable axillary lymph nodes \\> 1 cm\n  * Survivin- and/or carcinoembryonic antigen-positive by IHC\n  * Tumor must be localized by exam or ultrasound to allow tumor injection\n  * No stage IV or metastatic disease\n* HER2/neu-negative tumor by IHC\n\n  o If 2+ or in the indeterminate range, further testing of HER2/neu overexpression by fluorescent in situ hybridization (FISH) is required\n* Hormone receptor status known\n* Female\n* Pre-, peri-, or postmenopausal\n* ECOG performance status 0-1\n* Fertile patients must use effective contraception during and for up to 6 months following completion of study therapy\n* ANC \u2265 1,500/mm\u00b3\n* Platelet count \u2265 100,000/mm\u00b3\n* Alkaline phosphatase \u2264 1.5 times upper limit of normal (ULN)\n* Total bilirubin \u2264 1.5 times ULN\n* AST and ALT \u2264 1.5 times ULN\n* Creatinine \\< 1.5 times ULN\n\nExclusion Criteria:\n\n* No prior chemotherapy or radiotherapy\n* No active serious infections\n* No prior malignancy except adequately treated basal cell or squamous cell skin cancer, noninvasive carcinoma, or other cancer from which the patient has been disease free for 5 years\n* No comorbidity or condition that would interfere with study assessments and procedures or preclude study participation\n* Not pregnant or nursing/negative pregnancy test",
    "sex": "FEMALE",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}